Neutrophil-to-lymphocyte ratio as a prognostic marker of adverse events of heart failure

Tashchuk, V.; Nesterovska, R.

dc.contributor.author	Tashchuk, V.
dc.contributor.author	Nesterovska, R.
dc.date.accessioned	2025-05-08T06:24:35Z
dc.date.available	2025-05-08T06:24:35Z
dc.date.issued	2021
dc.identifier.citation	Tashchuk V, Nesterovska R. Neutrophil-to-lymphocyte ratio as a prognostic marker of adverse events of heart failure In: Rusnak I, Suthar A, Kulachek V, Kulachek Y, Kovtun-Vodyanytska S, Levon V, et al. Trends in the development of Medicine, Biology and Pharmacy: collective monograph. Boston: Primedia eLaunch; 2021. p. 214-217	uk_UA
dc.identifier.other	DOI: 10.46299/ISG.2021.MONO.MED.I
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26577
dc.language.iso	en	uk_UA
dc.publisher	Primedia eLaunch	uk_UA
dc.title	Neutrophil-to-lymphocyte ratio as a prognostic marker of adverse events of heart failure	uk_UA
dc.type	Book	uk_UA